Dissemination (Meeting Coverage)

For a presentation at the 2022 European Committee for Treatment and Research in Multiple Sclerosis...

Data from a randomized controlled trial presented at the European Committee for Treatment and...

A prospective, longitudinal, multicenter study of 217 patients with neuromyelitis optica spectrum...

A new study suggests B-cell depleting anti-CD20 monoclonal antibodies (mAbs) such as ocrelizumab...

Anti-CD20 therapies do not fully resolve chronic, active/smoldering lesions, visible on MRI as...

For a variety of reasons, patients with relapsing-remitting MS (RRMS) together with their...

In patients with aged 10-17 and treated with fingolimod for up to 6 years in the PARADIGMS study,...

From observational, single-arm cohorts, autologous hematopoietic stem cell transplantation (AHSCT)...

At a prize-winning poster presented at the European Committee for Treatment and Research in...

A large study conducted in European nationwide data sources found no evidence that teriflunomide...

West Virginia has widespread cardiovascular disease (CVD), which may be associated with ancestry...

ASCVD is the primary cause of death for women despite having a later onset than it is for men, and...

The ORION-1 experiment showed that inclisiran, an RNAi treatment that prevents PCSK9 production in...

Although there are many genetic polymorphisms in the APOB gene, it is not known whether or not...

Patients (pts) who received methotrexate (MTX) in combination with placebo [PBO] co-therapy to...

It is impossible to meet the requirements of a community as a whole by developing the capacity to...

Emerging data from US cohort studies imply that the costs of gout and hyperuricemia are...

For the treatment of gout in chronic kidney disease CKD patients, there needs to be more...